Related Experiment Video
Updated: Aug 11, 2026
08:01
Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
Pharmacogenomic data sample collection and storage: ethical issues and policy approaches
1Université de Montréal, Centre de recherche en droit public, 3101 chemin de la Tour, Montreal H3T 1J7, Canada.
Pharmacogenomics
|March 7, 2006
Summary
Pharmacogenomic research using large population databases faces ethical, legal, and social challenges. Addressing these issues is crucial for integrating pharmacogenomics into clinical practice.
Area of Science:
- Genomics
- Bioethics
- Pharmacology
Background:
- Large population-based databases are increasingly vital for pharmacogenomic research.
- These databases facilitate the confirmation of associations between genetic variations and drug responses.
Purpose of the Study:
- To explore the ethical, legal, and social issues (ELSI) associated with pharmacogenomic research.
- To highlight the importance of addressing ELSI for the clinical integration of pharmacogenomics.
Main Methods:
- Perspective report analyzing ELSI in pharmacogenomic research.
- Case examples include Estonian Genome Project, UK Biobank, CARTaGENE, and GenomEUtwin.
Main Results:
- Access to large population databases is critical for validating pharmacogenomic findings.
- The successful integration of pharmacogenomics hinges on managing the ELSI of these large-scale projects.
Conclusions:
- Effective management of ethical, legal, and social issues is paramount for advancing pharmacogenomics.
- Overcoming ELSI challenges will determine the widespread adoption of pharmacogenomics in healthcare.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:12Analysis of Population Pharmacokinetic Data
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...